PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.79%
Revenue growth 1.25-1.5x ADI's 4.82%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
7.87%
Gross profit growth above 1.5x ADI's 5.19%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
20.72%
EBIT growth above 1.5x ADI's 10.15%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
12.68%
Operating income growth 1.25-1.5x ADI's 10.15%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
24.76%
Net income growth above 1.5x ADI's 6.58%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
24.49%
EPS growth above 1.5x ADI's 7.14%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
24.14%
Diluted EPS growth above 1.5x ADI's 7.22%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.22%
Share count expansion well above ADI's 0.13%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.32%
Diluted share count expanding well above ADI's 0.09%. Michael Burry would fear significant dilution to existing owners' stakes.
13.33%
Dividend growth above 1.5x ADI's 0.22%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
47.26%
OCF growth above 1.5x ADI's 20.71%. David Dodd would confirm a clear edge in underlying cash generation.
47.49%
FCF growth above 1.5x ADI's 19.82%. David Dodd would verify if the firm’s strategic investments yield superior returns.
47.46%
10Y revenue/share CAGR at 75-90% of ADI's 60.61%. Bill Ackman would press for new markets or product lines to narrow the gap.
40.65%
5Y revenue/share CAGR 1.25-1.5x ADI's 31.40%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
16.50%
Positive 3Y CAGR while ADI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
120.33%
10Y OCF/share CAGR 1.25-1.5x ADI's 98.70%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
63.52%
Below 50% of ADI's 186.27%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
18.07%
3Y OCF/share CAGR above 1.5x ADI's 4.89%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
128.52%
Net income/share CAGR above 1.5x ADI's 39.20% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
122.19%
5Y net income/share CAGR at 50-75% of ADI's 238.19%. Martin Whitman might see a shortfall in operational efficiency or brand power.
425.94%
3Y net income/share CAGR above 1.5x ADI's 11.13%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
12.26%
Below 50% of ADI's 203.82%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
1.64%
Below 50% of ADI's 99.29%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-4.74%
Negative 3Y equity/share growth while ADI is at 18.01%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
681.02%
10Y dividend/share CAGR above 1.5x ADI's 183.64%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
167.12%
5Y dividend/share CAGR above 1.5x ADI's 54.05%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
64.37%
3Y dividend/share CAGR above 1.5x ADI's 37.53%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
1.58%
AR growth is negative/stable vs. ADI's 8.19%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-5.65%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
6.28%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
10.11%
BV/share growth above 1.5x ADI's 1.74%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
4.74%
We have some new debt while ADI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
0.52%
R&D dropping or stable vs. ADI's 7.46%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-2.21%
We cut SG&A while ADI invests at 7.39%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.